GiantLeap vs MeMed
GiantLeap vs MeMed, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: GiantLeap is on 40/100 and MeMed on 61/100.
Where each one leads
GiantLeap
Leads on none of the measures we hold for both companies.
MeMed
- our overall score: 61/100 against 40/100
- agent readiness: 35/100 against 21/100
- domain rating: 46/100 against 3/100
- headcount: 99 against 7
- headcount growth: -8.4% against -19.7%
- funding raised: $196M against $8.9M
- LinkedIn following: 21,207 against 316
At a glance
| Measure | GiantLeap | MeMed |
|---|---|---|
| What it is | Science-backed platform for data-driven child development decisions at home. | MeMed develops and commercializes host immune response diagnostic solutions to address complex clinical dilemmas and improve patient outcomes. |
| Category | Healthcare, Diagnostics, Neurology, Education | Healthcare, Blood, Diagnostics, MedTech |
| Sells toBusiness model | B2C | B2B, B2G |
| Offering | Software | Software, Hardware |
| Founded | 2018 | 2009 |
| Headquarters | Tel Aviv, Israel | Tirat Carmel, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | GiantLeap | MeMed |
|---|---|---|
| Employees | 7 | 99 |
| Headcount growthLast 12 months | -19.7% | -8.4% |
| Total funding | $8.9M | $196M |
| Latest round | Unknown | Series E |
| LinkedIn followers | 316 | 21,207 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | GiantLeap | MeMed |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 40/100 | 61/100 |
| Traction | 44/100 | 60/100 |
| Team | Not published | 70/100 |
| Search visibility | 25/100 | 29/100 |
| Quality | 48/100 | 65/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | F (35/100) |
| Domain ratingLink authority, 0-100 | 3/100 | 46/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | GiantLeap | MeMed |
|---|---|---|
| Hosting | Not detected | Self Managed |
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Jquery |
| Analytics | Not detected | Google Analytics 4, Google Tag Manager |
GiantLeap vs MeMed: common questions
Which is better, GiantLeap or MeMed?
On our 0-100 score MeMed rates higher (61/100 against 40/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do GiantLeap and MeMed compare on the numbers?
MeMed leads on our overall score (61/100 against 40/100), agent readiness (35/100 against 21/100), domain rating (46/100 against 3/100), headcount (99 against 7), headcount growth (-8.4% against -19.7%), funding raised ($196M against $8.9M), LinkedIn following (21,207 against 316).
Read the full GiantLeap review and pricing or the MeMed review and pricing. You can also browse other GiantLeap alternatives we track.